摘要
目的 :探讨同一种药物采用不同治疗方案对小儿肺炎的效果。方法 :将80例小儿肺炎患儿随机分成两组 ,分别采用序贯治疗 (A组 )和常规治疗 (B组 )方案 ,运用药物经济学成本 -效果分析法进行评价。结果 :A组和B组总成本分别为617 20元、954 16元 ,有效率分别为87 5 %、95 % ,每增加1个单位效果A组较B组节省44 93元。结论 :A组方案为治疗小儿肺炎的较佳方案。
OBJECTIVE: To discuss the effectiveness of a drug in different therapeutic schemes for infant pneumonia METHODS:80 cases of infant pneumonia were divided ramdonly into two groups:A:sequential therapy;B:routine therapy Evaluation was carried out with pharmacoeconomic cost-effectiveness analysis RESULTS:The total costs were 617 20 yuans and 954 16 yuans and the effective rates were 87 5% and 95% in group A and B respectively An increase of 1% effective rate in group A saved 44 93 yuans in comparison with that in group B CONCLUSION:The therapeutic scheme of group A seems to be better in treating infant pneumonia
出处
《中国药房》
CAS
CSCD
2002年第4期216-217,共2页
China Pharmacy
关键词
治疗
小儿
肺炎
成本-效果分析
Verosef(cefradine)
infant pneumonia
cost-effectiveness analysis
sequential therapy
